TrialPloS one2016

Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.

Daniel J Fullen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.